Understanding anti-leukemia responses to donor lymphocyte infusion
MetadataShow full item record
CitationBachireddy, Pavan, and Catherine J Wu. 2014. “Understanding anti-leukemia responses to donor lymphocyte infusion.” Oncoimmunology 3 (1): e28187. doi:10.4161/onci.28187. http://dx.doi.org/10.4161/onci.28187.
AbstractDonor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti-leukemia immunity.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:14351312
- HMS Scholarly Articles